PMID- 19070630 OWN - NLM STAT- MEDLINE DCOM- 20090713 LR - 20240312 IS - 0039-128X (Print) IS - 1878-5867 (Electronic) IS - 0039-128X (Linking) VI - 74 IP - 7 DP - 2009 Jul TI - Membrane estrogen receptors activate metabotropic glutamate receptors to influence nervous system physiology. PG - 608-13 LID - 10.1016/j.steroids.2008.11.013 [doi] AB - Until recently, the idea that estradiol could affect cellular processes independent of nuclear estrogen receptors was often dismissed as artifact. This in spite of a large number of carefully controlled studies performed both within and outside the nervous system demonstrating estrogens regulate various intracellular signaling pathways by acting at the membrane surface of cells and/or at biological rates incompatible with the time course of genomic-initiated events. The concept that estradiol can act on surface membrane receptors to regulate nervous system function is now far less controversial. However, there is evidence that there may be multiple types of estrogen receptors on the membrane surface of cells. Determining the physiological relevance of each of these receptors is currently underway. Two important membrane estrogen receptors are in fact the classical estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) proteins, which is somewhat surprising based upon their well-established role in nuclear gene transcription. This review will focus on the mechanism by which surface-localized ERalpha and ERbeta stimulate intracellular signaling events in cells of the nervous system through activation of metabotropic glutamate receptors (mGluRs). This mechanism of estrogen receptor function also requires caveolin proteins, which provide the subcellular compartmentalization of the particular signaling components required for appropriate cell stimulation. The review will conclude with several examples of physiological processes under the apparent regulation of ER/mGluR signaling. FAU - Boulware, Marissa I AU - Boulware MI AD - Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455, United States. FAU - Mermelstein, Paul G AU - Mermelstein PG LA - eng GR - R01 NS041302/NS/NINDS NIH HHS/United States GR - R01 NS041302-04/NS/NINDS NIH HHS/United States GR - NS41302/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review DEP - 20081125 PL - United States TA - Steroids JT - Steroids JID - 0404536 RN - 0 (Estrogens) RN - 0 (Receptors, Estrogen) RN - 0 (Receptors, Metabotropic Glutamate) SB - IM MH - Animals MH - Cell Membrane/*metabolism MH - Estrogens/pharmacology MH - Humans MH - Nervous System Physiological Phenomena/*drug effects MH - Receptors, Estrogen/*metabolism MH - Receptors, Metabotropic Glutamate/*metabolism MH - Signal Transduction PMC - PMC2799184 MID - NIHMS165244 EDAT- 2008/12/17 09:00 MHDA- 2009/07/14 09:00 PMCR- 2009/12/29 CRDT- 2008/12/17 09:00 PHST- 2008/10/02 00:00 [received] PHST- 2008/11/06 00:00 [revised] PHST- 2008/11/07 00:00 [accepted] PHST- 2008/12/17 09:00 [entrez] PHST- 2008/12/17 09:00 [pubmed] PHST- 2009/07/14 09:00 [medline] PHST- 2009/12/29 00:00 [pmc-release] AID - S0039-128X(08)00293-6 [pii] AID - 10.1016/j.steroids.2008.11.013 [doi] PST - ppublish SO - Steroids. 2009 Jul;74(7):608-13. doi: 10.1016/j.steroids.2008.11.013. Epub 2008 Nov 25.